Cargando…
Kinetics of central macular thickness reduction in patients with macular edema after intravitreal drug therapy
BACKGROUND: The purpose of this study was to characterize central macular thickness and retinal volume following intravitreal injections using time domain and spectral domain optical coherence tomography (TD-OCT and SD-OCT, respectively). METHODS: Nine patients with macular edema secondary to diabet...
Autores principales: | He, Lingmin, Chan, Annie, Leng, Theodore, Blumenkranz, Mark S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245197/ https://www.ncbi.nlm.nih.gov/pubmed/22205836 http://dx.doi.org/10.2147/OPTH.S26631 |
Ejemplares similares
-
Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex(®)) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion
por: Chan, Annie, et al.
Publicado: (2011) -
Efficiency of fenofibrate in facilitating the reduction of central macular thickness in diabetic macular edema
por: Srinivasan, Srilakshmi, et al.
Publicado: (2018) -
Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema
por: O’Day, Roderick, et al.
Publicado: (2013) -
Influence of Intravitreal Therapy on Choroidal Thickness in Patients with Diabetic Macular Edema
por: Udaondo Mirete, Patricia, et al.
Publicado: (2023) -
Aqueous cytokine levels are associated with reduced macular thickness after intravitreal ranibizumab for diabetic macular edema
por: Shiraya, Tomoyasu, et al.
Publicado: (2017)